We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Editas Medicine Raises $120 Million to Advance Genome Editing

News   Aug 12, 2015

 
Editas Medicine Raises $120 Million to Advance Genome Editing
 
 
 

RELATED ARTICLES

A Counting Game: Quantifying CRISPR’s Off-target Effects

News

Scientists are finding new ways to improve the use of the CRISPR enzyme Cas9 and reduce the chances of off-target mutations in laboratory mice, according to new results.

READ MORE

Plant-based Compound Helps Overcome Gene Therapy Challenges

News

Researchers believe they have found a way to sidestep some of the current difficulties associated with gene therapy, resulting in a better method that would save money and improve treatment outcomes.

READ MORE

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE